Dauvilliers Y, Mignot E, Antczak J, Arnulf I, Barateau L, Buntinx E, Corser B, Iranzo A, Khatami R, Lammers GJ, Lederer K, Nilsen KB, Pizza F, Schmidt MH, Sivam S, Sum-Ping O, Taniguchi M, Zhan S, Abraham A, Cai A, Du Y, Etherton MR, Faessel H, Hsiao S, Kadali H, Koundourakis E, Naylor M, Neuwirth R, Olsson T, Rogers R et al. (2026)
Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials
N Engl J Med (in press)
DOI 10.1056/NEJMoa2601598, PubMed 42714024

Ihle-Hansen H, Ihle-Hansen H, Blauenfeldt RA, Dawson J, Diederichsen SZ, Hagberg G (2026)
Cardiometabolic drugs after stroke: time to embrace SGLT2 inhibitors and incretin-based therapies?
Front Stroke, 5, 1918465
DOI 10.3389/fstro.2026.1918465, PubMed 42712498

Gundersen V, Strøm NJ, Broch BB, Aarli Å, Ruud KJ (2026)
Feil diagnose ved skjønnsmessig vurdering av hjernerystelse
Tidsskr Nor Laegeforen, 146 (10)
DOI 10.4045/tidsskr.26.0127, PubMed 42709000